Hsbc Holdings PLC Intra Cellular Therapies, Inc. Transaction History

Hsbc Holdings PLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$64.76 - $79.84 $821,933 - $1.01 Million	-12,692 Reduced 47.57%	13,986 $957,000
Q1 2024 May 15, 2024	BUY	$64.37 - $75.65 $1.4 Million - $1.64 Million	21,692 Added 435.06%	26,678 $1.85 Million
Q4 2023 Feb 12, 2024	BUY	$46.37 - $73.65 $3,153 - $5,008	68 Added 1.38%	4,986 $357,000
Q3 2023 Nov 13, 2023	BUY	$52.09 - $64.1 $65,581 - $80,701	1,259 Added 34.41%	4,918 $256,000
Q2 2023 Aug 11, 2023	BUY	$54.67 - $66.44 $200,037 - $243,103	3,659 New	3,659 $231,000
Q4 2022 Feb 14, 2023	BUY	$44.07 - $54.45 $174,252 - $215,295	3,954 New	3,954 $209,000
Q1 2021 May 14, 2021	SELL	$30.8 - $39.51 $279,910 - $359,066	-9,088 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$23.34 - $32.22 $212,113 - $292,815	9,088 New	9,088 $288,000
Q3 2020 Nov 12, 2020	SELL	$17.61 - $31.86 $210,263 - $380,408	-11,940 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$14.35 - $26.64 $171,339 - $318,081	11,940 New	11,940 $306,000
Q4 2019 Feb 14, 2020	SELL	$7.26 - $38.49 $266,108 - $1.41 Million	-36,654 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$7.47 - $14.03 $273,805 - $514,255	36,654 New	36,654 $274,000
Q4 2018 Feb 13, 2019	SELL	$10.36 - $20.96 $500,978 - $1.01 Million	-48,357 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$17.77 - $22.9 $653,776 - $842,513	36,791 Added 318.1%	48,357 $1.05 Million
Q2 2018 Aug 10, 2018	SELL	$17.33 - $23.4 $1.44 Million - $1.95 Million	-83,242 Reduced 87.8%	11,566 $204,000
Q1 2018 May 11, 2018	BUY	$15.16 - $25.49 $1.44 Million - $2.42 Million	94,808 New	94,808 $2 Million

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.92B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.